CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 140 filers reported holding CHINA BIOLOGIC PRODS INC in Q4 2016. The put-call ratio across all filers is 1.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $11,188,000 | -6.2% | 98,976 | -16.9% | 0.32% | -9.7% |
| Q1 2017 | $11,922,000 | -6.9% | 119,126 | 0.0% | 0.36% | -3.2% |
| Q4 2016 | $12,810,000 | +32.2% | 119,126 | +53.0% | 0.37% | +29.7% |
| Q3 2016 | $9,690,000 | -15.2% | 77,882 | -27.2% | 0.29% | -16.9% |
| Q2 2016 | $11,423,000 | -6.8% | 107,013 | 0.0% | 0.34% | -9.5% |
| Q1 2016 | $12,253,000 | +2.3% | 107,013 | +27.4% | 0.38% | +2.4% |
| Q4 2015 | $11,973,000 | +58.7% | 84,000 | 0.0% | 0.37% | +44.4% |
| Q3 2015 | $7,545,000 | +227.6% | 84,000 | +320.0% | 0.26% | +262.0% |
| Q2 2015 | $2,303,000 | – | 20,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPQ Asia Capital Ltd | 228,777 | $24,597,000 | 12.30% |
| Ariose Capital Management Ltd | 238,841 | $25,680,000 | 8.36% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 8,400 | $903,000 | 3.21% |
| RUDMAN ERROL M | 37,001 | $3,978,000 | 2.76% |
| INDUS CAPITAL PARTNERS, LLC | 167,104 | $17,967,000 | 2.33% |
| Ativo Capital Management LLC | 90,748 | $9,757,000 | 2.30% |
| THOMAS WHITE INTERNATIONAL LTD | 130,130 | $13,991,000 | 2.08% |
| OBERWEIS ASSET MANAGEMENT INC/ | 55,855 | $6,006,000 | 1.80% |
| Cormorant Asset Management, LP | 112,867 | $12,135,000 | 1.64% |
| BARING ASSET MANAGEMENT Ltd | 143,512 | $15,430,000 | 1.06% |